Amazon Biotech Informs Shareholders of Unauthorized 8K Filing

NEW YORK, NY--(Marketwire - June 17, 2008) - Amazon Biotech, Inc. (OTCBB: AMZO) (FRANKFURT: B2DA) announced that an 8K was filed by Amazon’s former employee, Michael Kanovsky, on June 13, 2008, alleging that a written consent of the Board of Directors issuing shares as compensation in lieu of debt owed to a creditor of the company was never signed by the members of the Board of Directors.

MORE ON THIS TOPIC